Dell Emc Healthcare Powerchat

In this episode, Abe Stern, Sr. Data Scientist on the Healthcare Team for NVIDIA, begins by defining the drug discovery process, its goals and an overview of the phases of the process. Abe discusses the challenges in drug discovery using traditional scientific computing, which include astronomical chemical permutations and combinations. Abe then describes how AI helps modernize the phases of sequencing and protein structure determination, docking, molecular simulation, and pharmaco kinetic property prediction. Abe concludes with the resources NVIDIA offers for researchers looking to exploit AI in the drug discovery process, how Dell supports these solutions, where to find more information, and final thoughts.